NEW YORK--(BUSINESS WIRE)--OverT Bio, a data-driven company working to unlock the curative potential of cell therapies in solid tumors, announced today that it has raised $16 million in seed funding.

OverT Bio, a biotechnology company developing next-generation therapies for solid tumors, today announced the formation of its Clinical Advisory Board, comprised of internationally recognized leaders ...

Despite the development of covert security technologies, overt solutions are still very important when it comes to product security strategies. Despite the development of covert security technologies, ...

“Racism is a simple ego trick of believing in validating the self by validating one’s group and at the expense of others. It’s a reflection of fear.” — Christian Sundberg, author “I imagine one of the ...

OverT combines cutting-edge cell engineering technologies with big data approaches to address major unmet medical needs in solid tumors “Cell therapies have shown, at least in blood cancers, that we ...